A Preliminary Study Evaluating The Influence of Ombitasvir, Paritaprevir and Dasabuvir +/- Ribavirin on Glucose Metabolism.
Latest Information Update: 19 Oct 2016
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 19 Oct 2016 New trial record
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.